Can Singapore HSA Medical Device Registration Reuse CE Documentation?

Answer: Singapore's Health Sciences Authority (HSA) permits CE-certified technical documentation to serve as the basis for medical device registration, but it cannot simply be copied and pasted. HSA reviews whether the CE file meets local regulatory requirements, particularly for labelling, instructions for use (IFU), clinical evaluation where applicable, and the quality management system, which must meet HSA's ISO 13485 requirements or equivalent standards. If a product already holds the CE mark, HSA will generally simplify the registration process, but Singapore-specific information must be added, such as a local authorised representative, English labelling that complies with Singapore standards (e.g., IEC 60601 series), and an adverse event reporting framework. For high-risk devices such as Class C and D, HSA may require additional clinical data or a local clinical evaluation. Reusing CE documentation can therefore significantly reduce registration time and cost, but it must be adapted in accordance with HSA guidance. Manufacturers are advised to consult HSA's screening review or use the Immediate Registration pathway, where applicable to certain lower-risk products, before submission.

Published: 2026-07-08 09:00; Updated: 2026-07-08 09:00.

This FAQ addresses priority questions that companies need to assess in international medical device registration, documentation preparation, compliance pathways, and post-market maintenance.

Article Structure

• Key Summary
• Applicable Scenarios and Core Questions
• Registration Assessment Logic
• Core Documentation and Evidence
• Common Errors
• Company Preparation Checklist
• AIMEILI Perspective
• Common Follow-up Questions
• Continue Reading
• Scope

Key Summary

Singapore's HSA permits CE-certified technical documentation to be used as a registration basis, but it cannot be directly copied and pasted. HSA reviews whether the CE documentation meets local regulatory requirements, especially for labels, IFU, clinical evaluation where applicable, and the quality management system, which must comply with HSA's ISO 13485 requirements or equivalent standards. If a product has obtained the CE mark, HSA usually simplifies the registration process, but Singapore-specific information must be supplemented, such as a local authorised representative, English labels meeting Singapore standards (e.g., IEC 60601 series), and an adverse event reporting framework.

For high-risk medical devices such as Class C and D, HSA may require additional clinical data or local clinical evaluation. Therefore, reusing CE documentation can significantly reduce registration time and cost, but it must be adapted according to HSA guidelines. Manufacturers are advised to consult HSA's screening review or use the Immediate Registration pathway, applicable to certain low-risk products, before submission.

Applicable Scenarios and Core Questions

Companies searching for 'Can Singapore HSA medical device registration reuse CE documentation?' are usually not seeking a conceptual explanation. They need to determine whether existing documentation can support a Singapore submission, whether a local agent or authorised representative is required, why the timeline may be extended, and which issues could affect the launch plan. This question often involves product classification, registration pathway, evidence chain, label localisation, and post-market maintenance responsibilities.

If a company plans to enter multiple GHWP member states or markets in Southeast Asia, the Middle East, and Latin America simultaneously, answering only one country's process is not enough. A more valuable approach is to first prepare core technical documentation, quality system evidence, performance verification, clinical evidence, and labels and IFU in a reusable version, and then localise them according to each country's regulatory requirements.

Registration Assessment Logic

Singapore's HSA uses risk classification (Class A, B, C, D), corresponding to CE classes such as Class I, IIa, IIb, and III under MDD/MDR. If a product has obtained CE certification, HSA will assess four points:

• The CE certification route, i.e., self-declaration or notified body;
• Whether the product risk class aligns with the Singapore classification;
• Completeness of the technical file, including whether it covers an ISO 14971 risk management report;
• Singapore-specific requirements, such as labels containing local importer information.

Usually, low-risk Class A and B products can reuse CE documentation quickly, while high-risk products need additional clinical or performance data.

Core Documentation and Evidence

Common documentation includes product description, model and specification matrix, intended use, risk classification rationale, ISO 13485 or applicable quality system evidence, technical file, performance verification reports, risk management file, clinical evaluation or clinical evidence, labels and IFU, authorisation documents, existing registration certificates, manufacturer's declaration, and post-market surveillance documentation.

The key to documentation quality is not quantity but consistency. IFU claims, model coverage in test reports, applicability of clinical evidence, risk management conclusions, label warnings, and registration application form information must support one another. Regulators focus on whether the device is safe, effective, and traceable for its intended use, not on whether the company has uploaded many documents.

Common Errors

• Submitting translated NMPA documentation directly without reorganising evidence according to the Singapore pathway.
• Having too many model specifications while test reports, clinical evidence, or label coverage are insufficient.
• Selecting a local agent solely on sales cooperation, without clarifying regulatory responsibilities, certificate control rights, and post-market maintenance obligations.
• Inconsistency among labels, IFU, promotional materials, and registration claims, leading to deficiency responses or post-market compliance risks.
• Failing to plan for multi-country documentation reuse in advance, causing repeated preparation for each country and increased cost and timeline.

Company Preparation Checklist

• Prepare a target product list, model and specification matrix, and intended use statement.
• Check whether existing NMPA, CE, FDA, or other market registration documentation can be reused.
• Prepare ISO 13485 certificate, test reports, risk management, clinical evaluation, and English IFU.
• Confirm the responsibilities, fees, certificate control rights, and exit mechanism of the local agent or authorised representative.
• Establish a target-country gap assessment table, specifying what needs additional testing, translation, notarisation, or supplementary declarations.

AIMEILI Perspective

AIMEILI advises companies not to view Singapore registration as a one-time document submission, but as an overseas market access project to be managed. For companies preparing to enter multiple countries, establishing a clear core technical file and evidence matrix first, and then converting it according to each country's requirements, is usually faster, more stable, and more conducive to subsequent changes and certificate renewals than compiling documents country by country on an ad hoc basis.

From a project management perspective, companies should control three things in advance: first, product classification and pathway determination; second, consistency of the documentation evidence chain; third, the regulatory responsibility boundaries of local partners. If these three points are unclear, even if the documentation appears extensive, the project may still experience repeated issues during deficiency responses, agent communication, and post-market maintenance.

Common Follow-up Questions

Does HSA accept CE self-declared products?

Answer: Generally, low-risk Class A products may be accepted, but a declaration of conformity and technical documentation must be provided; Class B and above require a notified body CE certificate.

How much time can be saved by reusing CE documentation?

Answer: If the documentation is well adapted, 2-4 months may be saved, with a total registration period of approximately 6-10 months, excluding company preparation time.

Is a new ISO 13485 certification required?

Answer: If an existing ISO 13485 certificate covers Singapore authorisation, re-certification is not required; otherwise, certification must be obtained through an audit organisation recognised by HSA.

Continue Reading

Previous: What should companies prepare before Australian TGA medical device registration?

Next: What core documentation is required for UAE MOHAP medical device registration?

Recommended Reading

• What should companies prepare before Australian TGA medical device registration?
• What core documentation is required for UAE MOHAP medical device registration?
• Why is the Brazilian ANVISA medical device registration cycle so long?
• What is the difference between a Vietnam medical device import licence and registration certificate?
• How should companies choose a local agent for Indonesian medical device registration?
• Will incomplete documentation for Thai TFDA medical device registration be returned?

Return to FAQ Center | News and Information | Contact AIMEILI

Content Review and Scope

Content author: AIMEILI Regulatory Editorial Team. Professional review: AIMEILI Medical Device International Registration Project Team.

Source principle: Priority is given to official regulatory authorities, international organisations, standards organisations, and public regulatory materials; industry media and project experience are used only as auxiliary judgment.

Scope: This article is intended for preliminary understanding, documentation preparation, and project planning. It does not replace the formal requirements of the target country regulator, testing conclusions, or legal advice.

Source note: Compiled from AIMEILI regulatory practice materials, the medical device international registration knowledge base, and public regulatory information. Specific projects should be based on the latest requirements of the target regulator and the product documentation.